Michal Mego

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

Mario Giuliano, Antonio Giordano, Summer Jackson et al. · Breast Cancer Research · 2011 · 224 citations · Full text

Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer

Antonio Giordano, Hui Gao, Simone Anfossi et al. · Molecular Cancer Therapeutics · 2012 · 223 citations · Full text

Breast Oncology, Cancer Stem Cell, Immunology +21

Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study

Michal Mego, Jozef Chovanec, Iveta Vochyanova-Andrezalova et al. · Complementary Therapies in Medicine · 2015 · 222 citations

Probiotic, Dysbiosis, Medicine +7

Expression of epithelial–mesenchymal transition‐inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

Michal Mego, Sendurai A. Mani, Bang‐Ning Lee et al. · International Journal of Cancer · 2011 · 161 citations · Full text

Emt-inducing Transcription Factors, Breast Oncology, Neoadjuvant Therapy +15

Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors

Zuzana Čierna, Michal Mego, Věra Miškovská et al. · Annals of Oncology · 2015 · 161 citations · Full text

Programmed-death-1 Receptor, Germ Cell, Malignant Disease +10